MedTrace Logo

Survival Study in Patients Undergoing On-line Hemodiafiltration

NCT00694031 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 906

Last updated 2014-02-28

No results posted yet for this study

Summary

Patients on hemodialysis will be randomly assigned (1:1) to continue on conventional hemodialysis or on-line hemodiafiltration, both three times per week. A 3 year follow-up and a sample size of around 750 will be necessary to detect a 35% reduction in mortality.

Conditions

  • Hemodialysis

Interventions

PROCEDURE

Hemodialysis

3 times per week

PROCEDURE

On-line hemodiafiltration

3 times per week

Sponsors & Collaborators

  • Societat Catalana de Nefrologia

    collaborator UNKNOWN

  • Hospital Clinic of Barcelona

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00694031 on ClinicalTrials.gov